OEM manufacturer Rivaroxaban Intermediates - Sorafenib CAS 284461-73-0 Purity ≥99.0% (HPLC) API Factory High Quality – Ruifu
OEM manufacturer Rivaroxaban Intermediates - Sorafenib CAS 284461-73-0 Purity ≥99.0% (HPLC) API Factory High Quality – Ruifu Detail:
Commercial Supply Sorafenib Tosylate and Related Intermediates:
Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
4-(4-Aminophenoxy)-N-Methylpicolinamide CAS: 284462-37-9
4-Chloro-3-(Trifluoromethyl)phenyl Isocyanate CAS: 327-78-6
Name | Sorafenib |
Synonyms | Sorafenib Free Base |
CAS Number | 284461-73-0 |
CAT Number | RF-API04 |
Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
Molecular Formula | C21H16ClF3N4O3 |
Molecular Weight | 464.82 |
Density | 1.454±0.06 g/cm3 |
Solubility | Soluble in DMSO |
Shipping Conditions | Ambient Temperature |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White to Off-White Powder |
Purity / Analysis Method | ≥99.0% (HPLC) |
Identification | H-NMR, MS |
Loss on Drying | ≤1.0% |
Residue on Ignition | ≤0.10% |
Single Impurity | ≤0.20% (HPLC) |
Total Impurities | ≤1.0% (HPLC) |
Heavy Metals | ≤20ppm |
Clarity of Solution | Conform to Standard |
Test Standard | Enterprise Standard |
Usage | RCC & HCC |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Sorafenib Tosylate (CAS: 475207-59-1) is a new type of multi-target antitumor drug, was developed by the German Bayer Pharmaceuticals, and displayed expansive antitumor activity in preclinical animal tests. Sorafenib is available in 200-mg tablets for oral administrationand is used in the treatment of RCC and HCC. Sorafenib Tosylate (CAS: 475207-59-1) can simultaneously affect tumor cells and tumor blood vessels. It has a double antitumor effect: it can block the cell signal transduction pathways mediated by RAF/MEK/ERK to directly inhibit tumor cell growth, while also inhibiting VEGF and platelet derived growth factors (PDGF) receptors to prevent the formation of new tumor blood vessels, thus indirectly inhibiting tumor cell growth. Sorafenib is an inhibitor of Raf-1 and B-RAF as well as several tyrosine kinases.
Product detail pictures:
Related Product Guide:
Sticking for the belief of "Creating items of top of the range and creating buddies with people today from all over the world", we normally put the interest of shoppers in the first place for OEM manufacturer Rivaroxaban Intermediates - Sorafenib CAS 284461-73-0 Purity ≥99.0% (HPLC) API Factory High Quality – Ruifu , The product will supply to all over the world, such as: Mali, Karachi, Moscow, If any product meed your demand, please feel free to contact us. We're sure your any inquiry or requirement will get prompt attention, high-quality products, preferential prices and cheap freight. Sincerely welcome friends all over the world to call or come to visit, to discuss cooperation for a better future!
By Hulda from United States - 2017.09.09 10:18
The manufacturer gave us a big discount under the premise of ensuring the quality of products, thank you very much, we will select this company again.
By Barbara from panama - 2017.06.19 13:51